Accéder au contenu
Merck
Toutes les photos(1)

Principaux documents

SRP3321

Sigma-Aldrich

MIF human

recombinant, expressed in insect cells, ≥98% (SDS-PAGE), ≥98% (HPLC)

Synonyme(s) :

GIF, GLIF, MMIF

Se connecterpour consulter vos tarifs contractuels et ceux de votre entreprise/organisme

Sélectionner une taille de conditionnement

25 μG
317.00 CHF

317.00 CHF


Date d'expédition estimée le14 avril 2025


Devis pour commande en gros

Sélectionner une taille de conditionnement

Changer de vue
25 μG
317.00 CHF

About This Item

Code UNSPSC :
12352200
Nomenclature NACRES :
NA.32

317.00 CHF


Date d'expédition estimée le14 avril 2025


Devis pour commande en gros

Source biologique

human

Produit recombinant

expressed in insect cells

Essai

≥98% (HPLC)
≥98% (SDS-PAGE)

Forme

lyophilized

Poids mol.

15.0 kDa

Conditionnement

pkg of 25 μg

Impuretés

endotoxin, tested

Numéro d'accès UniProt

Conditions d'expédition

wet ice

Température de stockage

−20°C

Informations sur le gène

human ... MIF(4282)

Description générale

Macrophage migration inhibitory factor (MIF) is a small secreted protein that can act as a pleiotropic pro-inflammatory cytokine as well as an enzyme. MIF pro-inflammatory activity can be initiated by signaling through cluster of differentiation 74 and 44 (CD74 and CD44), resulting in the secretion of tumor necrosis-α (TNF-α), interleukins-1, -6, -8, and various matrix metalloproteinases (MMPs). The gene encoding this protein is localized on human chromosome 22q11.23.[1][2] Insect cell derived recombinant MIF is a 15kDa protein containing 124 amino acid residues, including an N-terminal His-tag.

Actions biochimiques/physiologiques

The enzymatic activity of macrophage migration inhibitory factor (MIF) is characterized by its ability to act as a tautomerase, capable of catalyzing the keto to enol isomerization of keto-phenylpyruvate and L-dopachrome. It appears as though MIF catalytic activity is dependent upon a trimeric configuration and a free N-terminal proline residue.[3]

Forme physique

Lyophilized from 10mM Sodium Phosphate, pH 7.0.

Reconstitution

Centrifuge the vial prior to opening. Reconstitute in water to a concentration of 0.1-1.0 mg/ml. Do not vortex. This solution can be stored at 2-8°C for up to 1 week. For extended storage, it is recommended to further dilute in a buffer containing a carrier protein (example 0.1% BSA) and store in working aliquots at -20°C to -80°C.

Code de la classe de stockage

11 - Combustible Solids

Classe de danger pour l'eau (WGK)

WGK 3

Point d'éclair (°F)

Not applicable

Point d'éclair (°C)

Not applicable


Faites votre choix parmi les versions les plus récentes :

Certificats d'analyse (COA)

Lot/Batch Number

Vous ne trouvez pas la bonne version ?

Si vous avez besoin d'une version particulière, vous pouvez rechercher un certificat spécifique par le numéro de lot.

Déjà en possession de ce produit ?

Retrouvez la documentation relative aux produits que vous avez récemment achetés dans la Bibliothèque de documents.

Consulter la Bibliothèque de documents

Dual role of macrophage migration inhibitory factor (MIF) in human breast cancer.
Verjans E
BMC Cancer, 9, 230-230 (2009)
Crystal J DiCosmo-Ponticello et al.
Cytokine, 69(1), 47-55 (2014-07-16)
Macrophage migration inhibitory factor (MIF) is a pro-inflammatory cytokine that was initially identified by its ability to inhibit the movement of macrophages. Cell migration is a highly complex process involving changes to the cytoskeleton and cell adhesion molecules, and is
Inhibition of MIF bioactivity by rational design of pharmacological inhibitors of MIF tautomerase activity.
Dios A
Journal of Medicinal Chemistry, 45(12), 2410-2416 (2002)
Eric F Morand et al.
Frontiers in bioscience : a journal and virtual library, 10, 12-22 (2004-12-04)
Rheumatoid arthritis is characterised by the interaction of multiple mediators, among the most important of which are cytokines. In recent years, extensive data demonstrates a pivotal role for one cytokine, macrophage migration inhibitory factor (MIF), in fundamental events in innate
Yao Mawulikplimi Adzavon et al.
Cell communication and signaling : CCS, 16(1), 70-70 (2018-10-24)
Benign Lymphoepithelial Lesion (BLEL) is a rare disease observed in the adult population. Despite the growing numbers of people suffering from BLEL, the etiology and mechanisms underlying its pathogenesis remain unknown. In the present study, we used gene and cytokines

Questions

Reviews

No rating value

Active Filters

Notre équipe de scientifiques dispose d'une expérience dans tous les secteurs de la recherche, notamment en sciences de la vie, science des matériaux, synthèse chimique, chromatographie, analyse et dans de nombreux autres domaines..

Contacter notre Service technique